Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

10/31/06 Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.        

10/30/06 Northwest Biotherapeutics Discusses Results From Clinical Trials in Brain Cancer at Two Conferences        

10/30/06 Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer Seeking a Cure for Glioblastoma Multiforme, Other Deadly Cancers        

10/26/06 Reata Announces Receipt of Orphan Drug Status for RTA 744 in Treatment of Malignant Glioma        

10/18/06 Research Yields Clues to Radiation-Resistant Brain Cancer        

10/17/06 Have a Chance Walk for brain tumors.. NYC Oct 29, 2006        

10/17/06 Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).        

10/17/06 A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.        

10/17/06 PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium.        

10/17/06 Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.        

10/17/06 Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme.        

10/17/06 Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma.        

10/17/06 Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.        

10/17/06 Monitoring the effects of BCNU chemotherapy Wafers (Gliadel((R))) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.        

10/16/06 Tug McGraw Foundation and Honorary Chairman Tim McGraw to Honor Those Who Make a Difference at Benefit in Philadelphia        

10/16/06 Don't miss the upcoming FREE teleconferences from NBTF!        

10/13/06 Peregrine Pharma Gets Regulatory Approval To Test Cotara Brain Cancer Therapy In India - Update        

10/11/06 Risk of brain tumors associated with exposure to exogenous female sex hormones.        

10/04/06 NY Islanders Hockey Fundraiser to support brain tumor research        

---

Displaying Stories 4081 to 4100 of 7673
Previous 20           Next 20